How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

32,045 results for

Hypertension Evaluation History

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

before adding more. Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03756103 Recruitment Status : Not yet recruiting First Posted (...) : November 28, 2018 Last Update Posted : December 5, 2018 See Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd Collaborator: R&G Pharma Studies Co.,Ltd. Information provided by (Responsible Party): Shanghai Pharmaceuticals Holding Co., Ltd Study Details Study Description Go to Brief Summary: SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for essential hypertension. This is a phase IIa trial which designed to evaluate its efficacy and safety on treating mild-moderate essential

2018 Clinical Trials

182. Moderato System in Patients With Hypertension

Medical Labs GmbH nabios GmbH Information provided by (Responsible Party): BackBeat Medical Inc Study Details Study Description Go to Brief Summary: The purpose of this double blind randomized study is the evaluation of the safety and efficacy of the Moderato System. The Moderato implantable pulse generator is indicated for patients who have hypertension and also require a dual chamber pacemaker in order to reduce their blood pressure. In this amended CS-03 protocol Version 3.0, the study (...) will evaluate the safety and efficacy in a randomized, double-blind study following active treatment vs. a control patient population for a period of 3 month for efficacy and 12 months for safety (In comparison to 6 months for patients under protocol CS-03 Ver 1.1, NCT02837445). The device will be considered to have a clinical effectiveness with regard to its anti-hypertension function if there is a statistically significant and clinically meaningful reduction in mean 24-hour ambulatory systolic blood

2018 Clinical Trials

183. Severity of primary open-angle glaucoma in patients with hypertension and diabetes (PubMed)

Severity of primary open-angle glaucoma in patients with hypertension and diabetes Primary open-angle glaucoma (POAG) is a progressive optic neuropathy with numerous risk factors. Its severity with associated risk factors remains a widely debated topic.To evaluate the severity of POAG in patients with hypertension (HTN) and diabetes or both.This hospital-based, cross-sectional descriptive study was conducted for a period of 18 months from January 2016 to June 2017. Diagnosed cases of POAG were (...) evaluated for severity with associated risk factors.A total of 221 patients were enrolled in the study. The mean age of the patients was 54.4 (SD ± 15.9) years with a male to female ratio of 0.93:1. Of the 221 patients, 68 (31%) had a family history of POAG. Mean intraocular pressure was 15.8±4.87 mmHg, and mean central corneal thickness was 535.4±34.9 μm. A total of 81 (36%) patients had HTN, 21 (9.50%) had diabetes mellitus (DM), and 15 (6.80%) had both HTN and DM. Analysis using SPSS version 20

Full Text available with Trip Pro

2018 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

184. Pregnancy‐Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population‐Based Norwegian Cohort (PubMed)

. The burden of hypertension associated with pregnancy-related risk factors was evaluated using an attributable fraction method. A total of 1480 women developed pharmacologically treated hypertension within the follow-up among 60 027 women (rate of hypertension, 3.6/1000 person-years). The proportion of hypertension associated with a history of preeclampsia/eclampsia, gestational hypertension, preterm delivery, and pregestational or gestational diabetes mellitus was 28.6% (95% confidence interval, 25.5 (...) Pregnancy‐Related Risk Factors Are Associated With a Significant Burden of Treated Hypertension Within 10 Years of Delivery: Findings From a Population‐Based Norwegian Cohort The association between pregnancy complications and women's later cardiovascular disease has, primarily, been evaluated in studies lacking information on important covariates. This report evaluates the prospective associations between pregnancy-related risk factors (preeclampsia/eclampsia, gestational hypertension

Full Text available with Trip Pro

2018 Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

185. Sleep Duration and Hypertension: Analysis of > 700,000 Adults by Age and Sex (PubMed)

Sleep Duration and Hypertension: Analysis of > 700,000 Adults by Age and Sex The objective of this study was to evaluate the cross-sectional relationship between sleep duration and hypertension in a large, nationally-representative dataset that spans 10 years. This analysis may provide detailed information with high resolution about how sleep duration is related to hypertension and how this differs by demographic group.Data were aggregated from the 2013 Behavioral Risk Factor Surveillance (...) System (n = 433,386) and the combined 2007-2016 National Health Interview Surveys (n = 295,331). These data were collected by the Centers for Disease Control and Prevention from nationally-representative samples. Surveys were combined, and survey-specific weights were used in all analyses. Sleep duration was assessed with the item, "On average, how many hours of sleep do you get in a 24-hour period?" in both surveys. Hypertension was assessed as self-reported history. Covariates were assessed

Full Text available with Trip Pro

2018 Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

186. Effects of Beetroot Juice in Postmenopausal and Hypertensive

in Postmenopausal and Hypertensive The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03620227 Recruitment Status : Completed First Posted : August 8, 2018 Last Update Posted : February 20, 2019 Sponsor: Federal University of Uberlandia Collaborators: Conselho Nacional de Desenvolvimento Científico e Tecnológico (...) Criteria: Women aged between 50 and 70 years; Amenorrhea of at least 12 months; Being in the postmenopausal phase; Be controlled hypertension; Be able to practice physical exercises on cycle ergometers; Submit a certificate attesting to the ability to practice physical exercises. Exclusion Criteria: Be uncompensated hypertensive in stages 2 and 3; To present a history of stroke or acute myocardial infarction; Be a smoker; To present physical problems or cardiovascular complications that prevent

2018 Clinical Trials

187. Hypertension Chronobiome

upright position with 5 minute intervals between measurements; History of Raynaud's phenomenon; Known allergy against natural latex rubber (contained in ABP bladder and tubing); Nursing or pregnant females. Phase 2: Inclusion Criteria (Deeply phenotyping non-dipping hypertensives) Inclusion Cohort 1 (case): non-dipping hypertensives 'NDHT' >18 years of age, Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ABP measurements, 24h mean wake SBP >145mmHg from 24hr (...) of age, Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ABP measurements, Healthy (as assessed by health history, physical exam and screening lab work), 24h mean wake SBP <130mmHg quantified per 24hr-ABPM, Own a smartphone. 4.3.3 Inclusion Cohort 3 (control): matched dipping hypertensives 'DHT' 1) >18 years of age, 2) Upper arm with intact skin, i.e. without areas of breached or injured skin visible, for ABP measurements, 24h mean wake SBP >145mmHg from 24hr

2018 Clinical Trials

188. Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern

(100). Please remove one or more studies before adding more. Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier (...) Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2018 Clinical Trials

189. Angiotensin 1-7 in Obesity Hypertension

Angiotensin 1-7 in Obesity Hypertension Angiotensin 1-7 in Obesity Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Angiotensin 1-7 in Obesity Hypertension The safety and scientific validity (...) of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03604289 Recruitment Status : Not yet recruiting First Posted : July 27, 2018 Last Update Posted : February 19, 2019 See Sponsor: Amy Arnold Collaborator: American Heart Association Information provided

2018 Clinical Trials

190. The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD

of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03604003 Recruitment Status : Not yet recruiting First Posted : July 27, 2018 Last Update Posted : July 27, 2018 See (...) The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The Role

2018 Clinical Trials

191. Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension

. Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03617458 Recruitment Status : Recruiting First Posted : August 6, 2018 Last Update Posted : September 26 (...) Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

192. The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

remove one or more studies before adding more. The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension (RADIANCE-II) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03614260 (...) cm Any history of cerebrovascular event or severe cardiovascular event, or history of stable or unstable angina within 12 months prior to consent Repeat (>1) hospitalization for hypertensive crisis within 12 months prior to screening period, or any hospitalization for hypertensive crisis within 3 months prior to screening period Chronic oxygen support or mechanical ventilation other than nocturnal respiratory support for sleep apnea Primary pulmonary hypertension Night shift workers Pregnant

2018 Clinical Trials

193. Health Disparities in Hypertension

with pharmacologic agents for hypertension Blood pressure >160/100 mmHg Smoked within the last year Regular night work or rotating shift work for the three months prior to the study Travel across more than three time zones during the three months prior to the study. Any acute, chronic or debilitating medical conditions, other than mild hypertension (140History of severe (...) Health Disparities in Hypertension Health Disparities in Hypertension - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Health Disparities in Hypertension The safety and scientific validity of this study

2018 Clinical Trials

194. Enhancing Systems of Care to Improve Hypertension Guideline Implementation

. Enhancing Systems of Care to Improve Hypertension Guideline Implementation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03563872 Recruitment Status : Withdrawn (Lack of funding) First Posted : June 20, 2018 Last Update Posted : February 25, 2019 Sponsor: Henry Ford Health System Information provided (...) Enhancing Systems of Care to Improve Hypertension Guideline Implementation Enhancing Systems of Care to Improve Hypertension Guideline Implementation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

195. Spironolactone Versus Indapamide in Obese and Hypertensive Patients

Indapamide in Obese and Hypertensive Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03626506 Recruitment Status : Not yet recruiting First Posted : August 13, 2018 Last Update Posted : August 15, 2018 See Sponsor (...) with essential hypertension and visceral obesity will be evaluated. Condition or disease Intervention/treatment Phase Hypertension Drug: Spironolactone Drug: Indapamide Drug: Amlodipine Not Applicable Detailed Description: Thiazide diuretics have been widely used for the management of essential hypertension, especially in patients with salt-sensitive hypertension. Most recent guidelines continue to recommend thiazide diuretics as first-line agents for all patients with hypertension in spite of the potential

2018 Clinical Trials

196. Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

studies before adding more. Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03635125 Recruitment Status : Completed First Posted : August 17, 2018 Last Update Posted : August 20, 2018 Sponsor: Trinity (...) Hypertension & Metabolic Research Institute Information provided by (Responsible Party): Trinity Hypertension & Metabolic Research Institute Study Details Study Description Go to Brief Summary: Study is to evaluate the effect of Nebivolol to treat high blood pressure compared to an already approved drug, Metoprolol ER with background treatment of Amlodipine. Condition or disease Intervention/treatment Phase JNC 7 Stage 1 or 2 Hypertension Drug: Nebivolol I Drug: Nebivolol II Other: Baseline Washout Phase

2018 Clinical Trials

197. Learning Implementation of Guideline-based Decision Support System for Hypertension Treatment (LIGHT)

remove one or more studies before adding more. Learning Implementation of Guideline-based Decision Support System for Hypertension Treatment (LIGHT) (LIGHT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03636334 Recruitment Status : Enrolling by invitation First Posted : August 17, 2018 Last Update (...) Posted : March 21, 2019 Sponsor: China National Center for Cardiovascular Diseases Information provided by (Responsible Party): China National Center for Cardiovascular Diseases Study Details Study Description Go to Brief Summary: This trial aims to evaluate the effectiveness of a guideline-based decision support system for hypertension management by physicians at primary health care (PHC) centers in China in order to improve the delivery of appropriate treatment and blood pressure (BP) control

2018 Clinical Trials

198. Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension.

one or more studies before adding more. Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension. (PAH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03476629 Recruitment Status : Enrolling by invitation First Posted : March 26, 2018 Last Update Posted (...) Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension. Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove

2018 Clinical Trials

199. Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

of saved studies (100). Please remove one or more studies before adding more. Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients (HEVRO) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details (...) age should have pregnancy test. At randomization visit, patients still meeting inclusion/exclusion criteria will be randomized (1:1) to either eplerenone (E) 25mg bd or valsartan (V) 160mg od for 8 weeks. At 8, 16 and 24 weeks, patients at both arms will be evaluated with ambulatory BP measurements primary, as well as home and office BP measurements. At week 8, patients with controlled hypertension (mean ambulatory blood pressure measurement (ABPM) <130/80mmHg), will continue in monotherapy

2018 Clinical Trials

200. Surgical Idiopathic Intracranial Hypertension Treatment Trial

Hypertension Treatment Trial (SIGHT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03501966 Recruitment Status : Recruiting First Posted : April 18, 2018 Last Update Posted : March 13, 2019 See Sponsor: Jaeb Center for Health (...) Surgical Idiopathic Intracranial Hypertension Treatment Trial Surgical Idiopathic Intracranial Hypertension Treatment Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Surgical Idiopathic Intracranial

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>